Skip to main content

NUCC-390 dihydrochloride (C09-1156-893)

Aladdin

Catalog No.
C09-1156-893
Manufacturer No.
N648446-100mg
Manufacturer Name
Aladdin Scientific
Quantity
1
Unit of Measure
EA
Price: $2,782.71
List Price: $3,091.90

NUCC-390 dihydrochloride is a novel and selective small-molecule CXCR4 receptor agonist. NUCC-390 dihydrochloride induces internalization of CXCR4 receptors and acts in an opposite way of AMD3100 ( HY-10046 ) NUCC-390 dihydrochloride promotes nerve

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Adding to cart… The item has been added
NUCC-390 dihydrochloride is a novel and selective small-molecule CXCR4 receptor agonist. NUCC-390 dihydrochloride induces internalization of CXCR4 receptors and acts in an opposite way of AMD3100 ( HY-10046 ) NUCC-390 dihydrochloride promotes nerve recovery of function after neurodegeneration in vivo .In VitroNUCC-390 dihydrochloride (10 μM) produces strong (Ca)i response, but this effect can be blocked by the known potent and selective CXCR4 antagonist AMD3100. NUCC-390 dihydrochloride (10 μM; pre-treatment 30 mins) leads to increased levels of pERK, it has the capability of stimulating signaling activity downstream of CXCR4 receptors. NUCC-390 dihydrochloride (10 μM; 2 hours) can induce CXCR4 receptor internalization, and non-treated cells exhibit some diffuse expression of CXCR4-YFP throughout the cytosol and clear expression in the cell membrane in HEK cells. NUCC-390 dihydrochloride (0-1.25 μM; 24 hours) boosts axonal growth in cultured cerebellar granule neurons (CGNs) via CXCR4. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: C8161 cells Concentration: 10 μM Incubation Time: Pre-treated 30 mins Result: Increased the level of pERK. Cell Proliferation AssayCell Line: Cerebellar granule neurons (CGNs) Concentration: 0 μM; 0.0625 μM; 0.25 μM; 1.25 μM Incubation Time: 24 hours Result: Stimulated axonal growth via CXCR4.In VivoNUCC-390 dihydrochloride (hind limb injection; 3.2 mg/kg; twice daily; 3 days) contributes to the functional and anatomical recovery of the neuromuscular junction (NMJ) following an acute nerve terminal damage by α-LTx in CD-1 mice. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Six to eight-week-old CD1 miceDosage: 3.2 mg/kg Administration: Hind limb injection; twice daily; 3 days Result: Promoted functional and anatomical recovery of the NMJ.Form:SolidIC50& Target:CXCR4. Specifications and Purity: 99%. Molecular Formula: C23H35Cl2N5O. Molecular Weight: 468.46.
UPC:
12352107
Condition:
New
Availability:
8-12 weeks
Weight:
1.06 Ounces
HazmatClass:
No
WeightUOM:
LB
MPN:
N648446-100mg
CAS:
2749281-71-6
Product Size:
100mg


Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.


"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."

LAB DIRECTOR


"We utilized Cenmed's capabilities for a variety of projects around the world. They are a valued partner and supplier."

PHARMACEUTICAL SUPPLY CHAIN LEADER


"The reps are very good at finding products for customers in this period of supply chain issues."

SCOTT BEHMAN


"Your customer service has been excellent and makes me excited about purchasing with Cenmed in the future!!"

PROCUREMENT + BILLING COORDINATOR AT PHARMA.